Thank you, Ji, and thank you, everyone for joining us today. Now we started the year providing annual guidance with quarterly ...
In subjects with elevated cardiovascular disease (CVD) risk, MRT-8102, a NEK7-directed molecular glue degrader in development for the treatment of NLRP3/IL-1/IL-6 driven inflammatory diseases, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback